ACAD R&D Expenses
Acadia Pharmaceuticals Inc · R&D Expenses
ACAD R&D Expenses
Latest reported$331.01Mperiod ending
ACAD TTM R&D Expenses ($8.45M → $331.01M)
TTM R&D Expenses
High-resolution chart · PNG
ACAD r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 331,009,000 | |
| 327,405,000 | |
| 328,802,000 | |
| 344,776,000 | |
| 323,553,000 | |
| 321,835,000 | |
| 303,249,000 | |
| 269,259,000 | |
| 359,616,000 | |
| 342,154,000 | |
| 351,619,000 | |
| 360,616,000 | |
| 284,989,000 | |
| 301,864,000 | |
| 361,575,000 | |
| 352,779,000 | |
| 330,008,000 | |
| 311,297,000 | |
| 239,415,000 | |
| 234,589,000 | |
| 296,107,000 | |
| 303,467,000 | |
| 319,130,000 | |
| 314,534,000 | |
| 257,073,000 | |
| 260,098,000 | |
| 240,385,000 | |
| 231,048,000 | |
| 221,538,000 | |
| 200,810,000 | |
| 187,163,000 | |
| 182,159,000 | |
| 165,468,000 | |
| 153,056,000 | |
| 149,189,000 | |
| 136,228,000 | |
| 125,620,000 | |
| 111,918,000 | |
| 99,284,000 | |
| 89,532,000 | |
| 82,448,000 | |
| 80,349,000 | |
| 73,869,000 | |
| 71,585,000 | |
| 69,808,000 | |
| 65,228,000 | |
| 60,601,000 | |
| 50,344,000 | |
| 40,646,000 | |
| 33,959,000 | |
| 26,721,000 | |
| 23,697,000 | |
| 20,843,000 | |
| 18,203,000 | |
| 18,794,000 | |
| 18,317,000 | |
| 18,075,000 | |
| 17,918,000 | |
| 17,309,000 | |
| 17,642,000 | |
| 18,449,000 | |
| 19,175,000 | |
| 20,578,000 | |
| 23,657,000 | |
| 27,907,000 | |
| 34,845,000 | |
| 41,584,000 | |
| 45,894,000 | |
| 50,076,000 | |
| 54,133,000 | |
| 56,750,000 | |
| 61,882,000 | |
| 65,394,000 | |
| 60,853,000 | |
| 57,943,000 | |
| 51,584,000 | |
| 50,774,000 | |
| 51,534,000 | |
| 49,399,000 | |
| 48,584,300 | |
| 40,550,200 | |
| 34,858,300 | |
| 30,847,900 | |
| 27,118,500 | |
| 24,976,800 | |
| 23,820,300 | |
| 23,454,000 | |
| 17,079,100 | |
| 11,155,900 | |
| 10,072,900 | |
| 8,454,300 |